ACABRUNAT ACALABRUTINIB CAPSULES

Get a Price/Quote

MOQ : 1 Bottle

ACABRUNAT ACALABRUTINIB CAPSULES Specification

Salt Composition
Acalabrutinib

Pacakaging (Quantity Per Box)
30 capsules per box

Dosage Form
Oral capsule

Origin of Medicine
Allopathic

Indication
Mantle cell lymphoma (MCL), Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL)

Drug Type
Other Types

Ingredients
Acalabrutinib

Physical Form
Capsules

Function
Bruton Tyrosine Kinase (BTK) Inhibitor

Recommended For
Treatment of certain blood cancers such as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL)

Dosage
100MG

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
Varies as per prescription

Storage Instructions
Store below 30C, protected from moisture and light

ACABRUNAT ACALABRUTINIB CAPSULES Trade Information

Minimum Order Quantity
1 Bottle

Main Domestic Market
All India

About ACABRUNAT ACALABRUTINIB CAPSULES

PRODUCT DETAILS

BRAND NAME: ACABRUNAT.

CONTENT: ACALABRUTINIB.

STRENGTH: 100MG.

PACKAGING: PACK OF 30 CAPSULES.

MANUFACTURED BY: NATCO.

Note :-ACABRUNAT Is A Prescription Drug And ShouldBe Used Under Proper Medical Guidance And Advice. Do Not Share The MedicineWith Others, Since They May Be Suffering From A Problem That Is Not EffectivelyTreated By This Drug.............

How Does ACABRUNAT Work?

ACABRUNAT contains acalabrutinib, which functions as a selective Bruton Tyrosine Kinase (BTK) inhibitor. By blocking BTK, this medication interferes with cancer cell growth and survival, making it effective for blood cancers like MCL and CLL. The targeted mechanism helps control disease progression and alleviates symptoms associated with these malignancies.

Proper Usage and Dosage Guidelines

ACABRUNAT is taken orally as capsules, with dosage determined by the prescribing physician based on individual patient needs. Patients should strictly follow the recommended schedule and instructions to maximize treatment efficacy and minimize side effects. It is important not to crush or chew the capsules and to take them consistently at the same time each day.

Benefits and Patient Suitability

This medicine is suitable for adults diagnosed with mantle cell lymphoma, chronic lymphocytic leukemia, or small lymphocytic lymphoma. ACABRUNAT offers a targeted treatment approach, with the potential to slow cancer progression and improve overall outcomes when used under appropriate supervision. It is not recommended for use in children, pregnant, or lactating women.

FAQs of ACABRUNAT ACALABRUTINIB CAPSULES:

Q: What is ACABRUNAT used for?

A: ACABRUNAT is recommended for the oral treatment of certain blood cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL) in adult patients.

Q: How should ACABRUNAT capsules be taken?

A: ACABRUNAT capsules should be taken orally as directed by your physician. Swallow the capsules whole without crushing or chewing, and follow the prescribed dosage schedule for optimal effectiveness.

Q: When should ACABRUNAT not be used?

A: ACABRUNAT should not be used if you have hypersensitivity to acalabrutinib or any inactive ingredients. It is also contraindicated during pregnancy and lactation.

Q: What side effects can occur with ACABRUNAT?

A: Common side effects include headache, diarrhea, fatigue, musculoskeletal pain, and bleeding. If you experience severe or persistent symptoms, consult your doctor promptly.

Q: Where should ACABRUNAT be stored?

A: Store ACABRUNAT capsules below 30C in an HDPE bottle, protected from moisture and light, to ensure maximum shelf life and product stability.

Q: How does ACABRUNAT benefit patients?

A: By inhibiting BTK, ACABRUNAT helps manage and slow the progression of certain blood cancers, potentially improving patient outcomes and quality of life.

Q: Is a prescription required for ACABRUNAT?

A: Yes, ACABRUNAT requires a valid medical prescription for purchase and use, ensuring appropriate and safe administration under healthcare supervision.

Tell us about your requirement